This cohort of RA subjects had stable disease and therapy, and CXCR5+Th17 cells were increased in RA subject receiving either non-biologic DMARDs or TNFi (with or without DMARDs as indicated in Table 1) (Fig. 1h). The gene discussed is CXCR5; the disease is rheumatoid arthritis.